GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $9,218,000 | +14.2% | 288,534 | +23.8% | 0.05% | +25.6% |
| Q1 2022 | $8,070,000 | +23.1% | 232,992 | +4.1% | 0.04% | +25.8% |
| Q4 2021 | $6,553,000 | +22.6% | 223,906 | +6.7% | 0.03% | +10.7% |
| Q3 2021 | $5,347,000 | -6.6% | 209,873 | +28.4% | 0.03% | -12.5% |
| Q2 2021 | $5,725,000 | +497.0% | 163,481 | +594.2% | 0.03% | +433.3% |
| Q1 2021 | $959,000 | +80.9% | 23,550 | +92.2% | 0.01% | +50.0% |
| Q4 2020 | $530,000 | -45.2% | 12,250 | -30.2% | 0.00% | -55.6% |
| Q3 2020 | $967,000 | +49.2% | 17,546 | +71.0% | 0.01% | +28.6% |
| Q2 2020 | $648,000 | +12860.0% | 10,260 | +11428.1% | 0.01% | – |
| Q1 2020 | $5,000 | – | 89 | +2866.7% | 0.00% | – |
| Q4 2019 | $0 | – | 3 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 177,414 | $14,103,000 | 11.50% |
| Fernwood Investment Management, LLC | 258,012 | $20,509,000 | 9.81% |
| Perceptive Advisors | 5,865,726 | $466,266,000 | 9.26% |
| ArchPoint Investors | 186,756 | $14,845,000 | 4.54% |
| STANSBERRY ASSET MANAGEMENT, LLC | 115,638 | $9,192,000 | 3.74% |
| Camber Capital Management LP | 730,000 | $58,028,000 | 2.95% |
| Profit Investment Management, LLC | 46,873 | $3,726,000 | 2.50% |
| Casdin Capital, LLC | 300,000 | $23,847,000 | 2.19% |
| SECTORAL ASSET MANAGEMENT INC | 174,594 | $13,878,000 | 2.07% |
| Corriente Advisors, LLC | 40,000 | $3,180,000 | 1.71% |